tm logo

Monitor this mark

View On USPTO

ZAVESCA
Live/Registered
REGISTERED AND RENEWED

on 05 May 2022

Last Applicant/ Owned by

Actelion Pharmaceuticals Ltd.

Gewerbestrasse 16

Allschwil

CH

CH-4123

Serial Number

85185312 filed on 25th Nov 2010

Registration Number

4089805 registered on 24th Jan 2012

in the Principal Register

Correspondent Address

Cheryl Foytlin

Cheryl Foytlin

ONE JOHNSON & JOHNSON PLAZA

NEW BRUNSWICK NJ 08933

Filing Basis

1. intent to use

Disclaimer

NO DATA

ZAVESCA

Pharmaceutical preparations for treating glycolipid storage diseases, including Gaucher's disease and Niemann-Pick type C disease

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for treating glycolipid storage diseases, including Gaucher's disease and Niemann-Pick type C disease

Mark Details

Serial Number

No 85185312

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T42007US1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

25.03.04 -

Backgrounds covered with circles or ellipses

Legal History

Show more

Status DateAction Taken
05th May 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05th May 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05th May 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05th May 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th Jan 2022TEAS SECTION 8 & 9 RECEIVED
24th Jan 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06th Mar 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06th Mar 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20th Jan 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20th Jan 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.